No Data
Express News | ImmunoPrecise Antibodies Appoints Kristin Taylor as Chief Financial Officer; Transition From Interim CFO to Permanent Role Effective Immediately
Express News | Immunoprecise Appoints Kristin Taylor as Chief Financial Officer
ImmunoPrecise Antibodies Unit, PGxAI to Develop AI Model to Predict Treatment Responses
ImmunoPrecise Antibodies (IPA) said Tuesday its BioStrand unit is partnering with PGxAI to create an adaptive artificial intelligence model to predict patient responses to drugs, transforming personal
Express News | ImmunoPrecise Antibodies' BioStrand Subsidiary To Collaborate With PGxAI To Develop An AI Model For Pharmacogenomics Recommendations Using LENSai
Express News | Ipa’s Subsidiary Biostrand and Pgxai Announce Strategic Collaboration to Develop First-in-Class AI Model for Pharmacogenomics Recommendations Using Lensai™
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai Technology
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) ("ImmunoPrecise" or "IPA" or the "Company"), a leader in AI-driven biotherapeutic research and technology, today announces that its subsidiary, BioStrand, has been honored with